loading

Coherus Biosciences Inc Stock (CHRS) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
15.80%
77.06
91.52 74.57 58.72 32.44
Cost Of Revenue
59.10%
34.59
84.57 32.70 24.85 16.87
Gross Profit
510.56%
42.48
6.957 41.87 33.87 15.56
Operating Expenses
12.05%
85.00
75.86 73.87 68.41 83.31
Interest Income/Expense
4.68%
11.12
10.62 10.27 9.943 9.712
Benefits Costs and Expenses
115.08%
-25.81
171.18 114.59 101.58 108.17
Costs And Expenses
25.46%
119.59
160.43 106.57 93.26 100.18
Depreciation and Amortization
41.77%
1.507
1.063 0.899 0.88 0.949
Operating Income/Loss
38.28%
-42.52
-68.91 -32.01 -34.54 -67.75
Income/Loss From Continuing Operations Before Tax
229.15%
102.88
-79.65 -40.02 -42.87 -75.73
Income/Loss From Continuing Operations After Tax
229.15%
102.88
-79.65 -39.64 -42.87 -75.73
Net Income/Loss
229.15%
102.88
-79.65 -39.64 -42.87 -75.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,816%
112.75
5.8847 97.74 87.27 79.27
Diluted Average Shares
2,033%
125.53
5.8847 97.74 87.27 79.27
Basic Earnings Per Share
222.97%
0.91
-0.74 -0.41 -0.49 -0.96
Diluted Earnings Per Share
212.16%
0.83
-0.74 -0.41 -0.49 -0.96
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):